A Novel Ex Vivo Assay to Evaluate Functional Effectiveness of Plasmodium vivax Transmission-Blocking Vaccine Using Pvs25 Transgenic Plasmodium berghei.

Published in: The Journal of infectious diseases (2024)

The MFA is expected to expedite Pvs25-based TBV development without dependence on blood from P. vivax-infected patients in endemic areas for evaluation.

Keyphrases

plasmodium falciparum
randomized controlled trial
systematic review
high throughput
single cell